✦ LIBER ✦

Response to understanding power calculations in clinical trials

✍ Scribed by Kari Salovaara; Marjo Tuppurainen; Heikki Kröger; Risto Honkanen

Publisher: American Society for Bone and Mineral Research
Year: 2010
Tongue: English
Weight: 38 KB
Volume: 25
Category: Article
ISSN: 0884-0431
DOI: 10.1002/jbmr.246

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Understanding power calculations in clin

Understanding power calculations in clinical trials

✍ Richard L Prince; Kun Zhu; Joshua R Lewis 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 43 KB

Physician response to informed consent r

Physician response to informed consent regulations for randomized clinical trials

✍ Kathryn M. Taylor; Marla Shapiro; Colin L. Soskolne; Richard G. Margolese 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB

POWER CONSIDERATIONS FOR CLINICAL TRIALS

POWER CONSIDERATIONS FOR CLINICAL TRIALS USING MULTIVARIATE TIME-TO-EVENT DATA

✍ MICHAEL D. HUGHES 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 2 views

Many clinical trials involve the collection of data on the times to occurrence of different types of events, such as different fungal infections in AIDS research, or of recurrences of the same type, such as successive fits in epilepsy research. The multivariate proportional hazards model allows for

S29.2: Flexible Testing in Clinical Tria

S29.2: Flexible Testing in Clinical Trials With Binary Response

✍ Hans-Helge Müller; Helmut Schäfer 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

Challenges to multiple testing in clinic

Challenges to multiple testing in clinical trials

✍ H. M. James Hung; Sue-Jane Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Response to commentaries on ‘Alpha calcu

Response to commentaries on ‘Alpha calculus in clinical trials: considerations for the new millennium’

✍ Lemuel A. Moyé 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 3 views